The Justice Department won a legal challenge against the combination last month. The company cited an "initial analysis of data" about the type of customers who signed up for its plans this year, and it said that it saw no evidence that the market was improving but that it was "seeing further signs of an unbalanced risk pool," as customers with expensive medical conditions continued to enroll as compared with healthy people. Humanaâ€™s move "could be a harbinger of things to come," said Sabrina Corlette, a research professor at Georgetown University who studies the health insurance market and who has warned that the lack of clarity from Congress and the Trump administration could result an exodus by insurers. " 